British HIV Association guidelines for antiretroviral treatment of HIV-2-positive individuals 2010.
Gilleece
Y
Y
British HIV Association (BHIVA), BHIVA Secretariat, Mediscript Ltd, London, UK. yvonne.gilleece@bsuh.nhs.uk
Chadwick
D R
DR
Breuer
J
J
Hawkins
D
D
Smit
E
E
McCrae
L X
LX
Pillay
D
D
Smith
N
N
Anderson
J
J
D015492:AIDS Serodiagnosis / Q000379:methods; D019380:Anti-HIV Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D004334:Drug Administration Schedule; D024882:Drug Resistance, Viral / Q000235:genetics*; D004359:Drug Therapy, Combination; D005260:Female; D015658:HIV Infections / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology; D015498:HIV-2; D006801:Humans; D020128:Inhibitory Concentration 50; D008826:Microbial Sensitivity Tests; D009154:Mutation; D011247:Pregnancy; D012367:RNA, Viral / Q000032:analysis; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*; D017211:Treatment Failure; D019562:Viral Load
D019380:Anti-HIV Agents; D012367:RNA, Viral; D018894:Reverse Transcriptase Inhibitors